Perspective Therapeutics (CATX) Current Leases (2019 - 2026)
Perspective Therapeutics recorded quarterly Current Leases of $1.1 million in Q1 2026, up 71.59% quarter-over-quarter from $623000.0 in Q4 2025, and up 9.08% year-over-year from $980000.0 in Q1 2025.
Perspective Therapeutics' Current Leases history runs 8 years deep, the most recent figure standing at $1.1 million for Q1 2026.
- In Q1 2026, Current Leases rose 9.08% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $1.1 million (up 9.08% YoY), while the FY2025 annual figure was $623000.0, down 34.9% from the prior year.
- Current Leases came in at $1.1 million for Q1 2026 at Perspective Therapeutics, up from $623000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $1.1 million in Q1 2026 to a low of $46000.0 in Q4 2023.
- A 5-year average of $538500.0 and a median of $458000.0 in 2023 frame the typical range for Current Leases.
- On a YoY basis, Current Leases climbed as much as 1980.43% in 2024 and fell as far as 54.29% in 2024.
- Perspective Therapeutics' Current Leases stood at $272000.0 in 2022, then plunged by 83.09% to $46000.0 in 2023, then surged by 1980.43% to $957000.0 in 2024, then slumped by 34.9% to $623000.0 in 2025, then jumped by 71.59% to $1.1 million in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $1.1 million, $623000.0, and $704000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 24.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 20.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 35.80 Mn |
| 10 | Perspective Therapeutics | 380.23 Mn | 380.23 Mn | - | 1.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.07 Mn |
| Dec 31, 2025 | 623,000.00 |
| Sep 30, 2025 | 704,000.00 |
| Jun 30, 2025 | 847,000.00 |
| Mar 31, 2025 | 980,000.00 |
| Dec 31, 2024 | 957,000.00 |
| Sep 30, 2024 | 903,000.00 |
| Jun 30, 2024 | 720,000.00 |
| Mar 31, 2024 | 128,000.00 |
| Dec 31, 2023 | 46,000.00 |
| Sep 30, 2023 | 293,000.00 |
| Jun 30, 2023 | 262,000.00 |
| Mar 31, 2023 | 280,000.00 |
| Sep 30, 2022 | 272,000.00 |
| Jun 30, 2022 | 268,000.00 |
| Mar 31, 2022 | 264,000.00 |
| Dec 31, 2021 | 260,000.00 |
| Sep 30, 2021 | 256,000.00 |
| Jun 30, 2021 | 252,000.00 |
| Mar 31, 2021 | 249,000.00 |
| Dec 31, 2020 | 245,000.00 |
| Sep 30, 2020 | 241,000.00 |
| Jun 30, 2020 | 236,000.00 |
| Mar 31, 2020 | 232,000.00 |
| Dec 31, 2019 | 229,000.00 |
| Sep 30, 2019 | 225,000.00 |